Stem cell-derived exosomes as a potential therapy for schistosomal hepatic fibrosis in experimental animals.

Schistosomiasis is a neglected tropical disease. Egg-induced granuloma formation and tissue fibrosis are the main causes of the high morbidity and mortality of schistosomiasis. Mesenchymal stem cells (MSCs)-derived exosomes play an important role with a superior safety profile than MSCs in the treatment of liver fibrosis. Therefore, the aim of this study was to investigate the potential therapeutic effect of MSCs-derived exosomes on schistosomal hepatic fibrosis. Exosomes were isolated from bone marrow MSCs and characterized. A total of 85 mice were divided into four groups: group I (control group), group II (PZQ group) infected and treated with PZQ, group III (EXO group) infected and treated with MSCs-derived exosomes and group IV (PZQ+EXO group) infected and treated with both PZQ and MSCs-derived exosomes. Assessment of treatment efficacy was evaluated by histopathological and immunohistochemical examination of liver sections by proliferating cell nuclear antigen (PCNA) and nuclear factor-κB (NF-κB). The results showed significant reduction of the number and diameter of hepatic granulomas, hepatic fibrosis, upregulation of PCNA expression and reduction of NF-κB expression in EXO and PZQ+EXO groups as compared to other groups at all durations post infection. Additionally, more improvement was observed in PZQ+EXO group. In conclusion, MSCs-derived exosomes are a promising agent for the treatment of schistosomal hepatic fibrosis, and their combination with PZQ shows a synergistic action including antifibrotic and anti-inflammatory effects. However, further studies are required to establish their functional components and their mechanisms of action.

[1]  Ranwa A. Elrayess,et al.  Parasitological and histopathological studies to the effect of aqueous extract of Moringa oleifera Lam. leaves combined with praziquantel therapy in modulating the liver and spleen damage induced by Schistosoma mansoni to male mice , 2022, Environmental Science and Pollution Research.

[2]  A. Mohamed,et al.  Protective role of Balanities aegyptiaca fruit aqueous extract in mice infected with Schistosoma mansoni. , 2022, Experimental parasitology.

[3]  M. Kulkarni,et al.  Charting the evidence for climate change impacts on the global spread of malaria and dengue and adaptive responses: a scoping review of reviews , 2022, Globalization and Health.

[4]  N. Holroyd,et al.  Morphological and genomic characterisation of the Schistosoma hybrid infecting humans in Europe reveals admixture between Schistosoma haematobium and Schistosoma bovis , 2021, PLoS neglected tropical diseases.

[5]  C. Carbonell,et al.  Clinical Spectrum of Schistosomiasis: An Update , 2021, Journal of clinical medicine.

[6]  L. Slovinská,et al.  New therapeutic approaches of mesenchymal stem cells-derived exosomes , 2021, Journal of Biomedical Science.

[7]  D. You,et al.  In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis , 2021, Frontiers in Bioengineering and Biotechnology.

[8]  Y. Nan,et al.  Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of in vivo studies , 2020, World journal of gastroenterology.

[9]  R. Abdel-Gaber,et al.  Cell therapy as a new approach on hepatic fibrosis of murine model of Schistosoma mansoni-infection , 2020, Acta Parasitologica.

[10]  R. Kalluri,et al.  The Biology and Therapeutic Potential of Mesenchymal Stem Cells derived Exosomes. , 2020, Cancer science.

[11]  Daigen Xu,et al.  Investigating the antifibrotic effect of the antiparasitic drug Praziquantel in in vitro and in vivo preclinical models , 2020, Scientific Reports.

[12]  H. Miller,et al.  T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis , 2020, Frontiers in Immunology.

[13]  D. Xie,et al.  Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage. , 2020, Life sciences.

[14]  Rongpeng Yao,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p , 2020 .

[15]  Bo Zhang,et al.  Bone marrow mesenchymal stem cell-derived hepatocyte-like cell exosomes reduce hepatic ischemia/reperfusion injury by enhancing autophagy. , 2020, Stem Cells and Development.

[16]  Xuefeng Wang,et al.  hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice , 2020, Stem Cell Research & Therapy.

[17]  Xiaowen He,et al.  Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. , 2019, JCI insight.

[18]  Q. Gong,et al.  The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis , 2019, Parasites & Vectors.

[19]  N. Arsenijević,et al.  Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases , 2019, Cells.

[20]  H. Abdel-Tawab,et al.  Pentoxifylline and/or praziquantel reduce murine schistosomiasis mansoni histopathology via amelioration of liver functions , 2019 .

[21]  Natasha T. Snider,et al.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73). , 2019, American journal of physiology. Cell physiology.

[22]  Jee‐Heon Jeong,et al.  Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. , 2019, European journal of cell biology.

[23]  Q. Shu,et al.  Functional proteins of mesenchymal stem cell-derived extracellular vesicles , 2019, Stem Cell Research & Therapy.

[24]  J. Bayo,et al.  Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice , 2019, Gene Therapy.

[25]  R. Resende,et al.  Enhancing the Therapeutic Potential of Mesenchymal Stem Cells with the CRISPR-Cas System , 2019, Stem Cell Reviews and Reports.

[26]  K. Rezvani,et al.  Mesenchymal stem cell-derived exosomes for clinical use , 2019, Bone Marrow Transplantation.

[27]  B. Puig,et al.  Generation and Function of Non-cell-bound CD73 in Inflammation , 2019, Front. Immunol..

[28]  L. Leyton,et al.  Thy-1/CD90 a Bidirectional and Lateral Signaling Scaffold , 2019, Front. Cell Dev. Biol..

[29]  T. Ochiya,et al.  The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity , 2019, Journal of clinical medicine.

[30]  N. E. Saleh,et al.  Effect of omega-3 fatty acids administered as monotherapy or combined with artemether on experimental Schistosoma mansoni infection. , 2019, Acta tropica.

[31]  N. Arsenijević,et al.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome , 2019, Cells.

[32]  Yimin Wang,et al.  Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway , 2019, Stem Cell Research & Therapy.

[33]  V. Ojili,et al.  Multisystem imaging review of human schistosomiasis: characteristic imaging findings. , 2019, Clinical imaging.

[34]  K. Yuyama,et al.  Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats , 2018, Stem cells international.

[35]  Jianping Cao,et al.  Toll-like receptor-2 regulates macrophage polarization induced by excretory-secretory antigens from Schistosoma japonicum eggs and promotes liver pathology in murine schistosomiasis , 2018, PLoS neglected tropical diseases.

[36]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[37]  M. Schlitzer,et al.  Chemotherapy for Fighting Schistosomiasis: Past, Present and Future , 2018, ChemMedChem.

[38]  R. Almeer,et al.  Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice , 2018, PloS one.

[39]  Zhiyong Ma,et al.  Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice , 2018, Parasitology Research.

[40]  H. Baharvand,et al.  Extracellular vesicles derived from human embryonic stem cell‐MSCs ameliorate cirrhosis in thioacetamide‐induced chronic liver injury , 2018, Journal of cellular physiology.

[41]  A. Semlali,et al.  Antischistosomal and anti-inflammatory activity of garlic and allicin compared with that of praziquantel in vivo , 2018, BMC Complementary and Alternative Medicine.

[42]  M. El-Magd,et al.  Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni , 2018, Journal of Parasitic Diseases.

[43]  W. Xia,et al.  Effect of pH, temperature and freezing-thawing on quantity changes and cellular uptake of exosomes , 2018, Protein & Cell.

[44]  S. Ding,et al.  Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis , 2018, World journal of gastroenterology.

[45]  I. Martin,et al.  Ectopic bone formation by aggregated mesenchymal stem cells from bone marrow and adipose tissue: A comparative study , 2018, Journal of tissue engineering and regenerative medicine.

[46]  Dina M. Abou Rayia,et al.  The Outcomes of Bone Marrow Stromal Cell Therapy in Schistosomal Hepatic Fibrosis : An Experimental Study , 2017 .

[47]  M. Yáñez-Mó,et al.  A bead-assisted flow cytometry method for the semi-quantitative analysis of Extracellular Vesicles , 2017, Scientific Reports.

[48]  T. Wynn,et al.  Mechanisms of Organ Injury and Repair by Macrophages. , 2017, Annual review of physiology.

[49]  S. Etewa,et al.  THE EFFECT OF STEM CELLS AS AN ADJUVANT ON THE IMMUNOGENICITY OF A POTENTIAL ANTI-SCHISTOSOMAL VACCINE IN MICE. , 2016, Journal of the Egyptian Society of Parasitology.

[50]  N. Puig,et al.  MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry , 2016, Cell Communication and Signaling.

[51]  S. Ng,et al.  Adipose-Derived Mesenchymal Stem Cell Exosomes Suppress Hepatocellular Carcinoma Growth in a Rat Model: Apparent Diffusion Coefficient, Natural Killer T-Cell Responses, and Histopathological Features , 2015, Stem cells international.

[52]  P. Bernard,et al.  Size and shape characterization of hydrated and desiccated exosomes , 2015, Analytical and Bioanalytical Chemistry.

[53]  G. Dworacki,et al.  Exosomes – Structure, Biogenesis and Biological Role in Non‐Small‐Cell Lung Cancer , 2015, Scandinavian journal of immunology.

[54]  M. Omary,et al.  Mouse hepatocyte overexpression of NF‐κB‐inducing kinase (NIK) triggers fatal macrophage‐dependent liver injury and fibrosis , 2014, Hepatology.

[55]  G. Khalaf,et al.  Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of CCL4 Induced Liver Fibrosis in Albino Rats: A Histological and Immunohistochemical Study , 2014, International journal of stem cells.

[56]  S. Lim,et al.  Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models , 2014, Stem Cell Research & Therapy.

[57]  D. Citrin,et al.  Mesenchymal stem cells inhibit cutaneous radiation‐induced fibrosis by suppressing chronic inflammation , 2013, Stem cells.

[58]  B. Wang,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. , 2013, Stem Cells and Development.

[59]  M. Kuroda,et al.  Roles of exosomes and microvesicles in disease pathogenesis. , 2013, Advanced drug delivery reviews.

[60]  Zhu Yuan,et al.  Expression of hPNAS-4 radiosensitizes Lewis lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[61]  A. Shakoori,et al.  Cytotoxic effect of cigarette smoke condensate on mice and rat mesenchymal stem cells and HeLa cells , 2012, Turkish Journal of Medical Sciences.

[62]  Bernd Giebel,et al.  Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. , 2011, Colloids and surfaces. B, Biointerfaces.

[63]  S. Smale,et al.  Selectivity of the NF-{kappa}B response. , 2010, Cold Spring Harbor perspectives in biology.

[64]  Suchittra Samuhasaneeto,et al.  Curcumin Decreased Oxidative Stress, Inhibited NF-κB Activation, and Improved Liver Pathology in Ethanol-Induced Liver Injury in Rats , 2009, Journal of biomedicine & biotechnology.

[65]  S. Lehmann,et al.  Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. , 2008, Experimental cell research.

[66]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[67]  Z. Demerdash,et al.  Correlation between Infection Intensity, Serum Immunoglobulin Profile, Cellular Immunity and the Efficacy of Treatment with Praziquantel in Murine Schistosomiasis mansoni , 2000, Arzneimittelforschung.

[68]  Z. Salehi,et al.  Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases , 2020 .

[69]  M. Zheng,et al.  BMSCs‐derived miR‐223‐containing exosomes contribute to liver protection in experimental autoimmune hepatitis , 2018, Molecular immunology.

[70]  R. Schuster,et al.  Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. , 2016, Journal of hepatology.

[71]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[72]  S. Han,et al.  In vitro endothelial potential of human UC blood-derived mesenchymal stem cells. , 2006, Cytotherapy.

[73]  A. Xagorari,et al.  G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. , 2005, Experimental hematology.